Alerts

Manasamitra Vakakam tablets pose a serious risk to your health and should not be taken.

Kumar Kalyan Rasa tablets pose a serious risk to your health and should not be taken.

Brahmi Vati tablets pose a serious risk to your health and should not be taken.

We have updated the product warnings for GLP-1 and dual GIP/GLP-1 receptor agonists for two separate safety issues. This relatively new and high-profile class of medicines is used to treat type 2 diabetes mellitus and/or obesity.

The safety information for denosumab products used to treat osteoporosis has been updated to strengthen the existing warning for multiple spinal fractures after discontinuation or delay of treatment.

We are aware of the recent report of a death of a child overseas. The death has been found to have been caused by a fire that occurred during the use of a hyperbaric chamber device.

We have investigated 2 serious adverse event cases in young babies who had EMLA (prilocaine/lidocaine cream) applied to their skin for local anaesthesia. Both cases were likely to have involved overdose.

TGA is issuing a safety advisory about the importation of unregistered GLP-1 products that are being promoted online for weight-loss.

We are issuing a safety advisory regarding imported unregistered melatonin products following testing by TGA Laboratories.

Our investigation into concerns about Vyvanse’s potential lack of effectiveness, quality and safety found no issues of concern.

We are issuing a safety advisory about the increasing importation and use of unregistered oral methylene blue (methylthioninium chloride) products in Australia.

We continue to receive reports of lead poisoning linked to imported or unregistered Ayurvedic medicines contaminated with heavy metals.

Using a home-use foetal heart monitor to check a baby’s heartbeat may seem reassuring but it can be dangerously misleading. We have received reports of instances where they have provided false reassurance, leading to delayed medical attention and infant deaths.

Consumers and health professionals should be aware that two unrelated cases of counterfeit injectable botulinum toxin products have been stopped at the Australian border.

Consumers and health professionals should be aware that examples of counterfeit products have been stopped at the Australian border. These tablets may pose a serious risk to your health and should not be used.

Consumers and health professionals should be aware that examples of counterfeit Roche labelled products have been stopped at the Australian border.

Consumers and health professionals should be aware that examples of substandard Fitaro semaglutide pre-filled syringes have been stopped at the Australian border.

The Therapeutic Goods Administration are continuing to see imports of counterfeit ivermectin.

Nhan Sam Tuyet Lien Truy Phong Hoan capsules pose a serious risk to your health and should not be taken.

Warnings added of risks during anaesthesia or deep sedation.

Updated illustrations clarify how to use measuring syringe for oral solutions.

We are aware of products being sold in Australia that claim to contain, or influence the levels of, nicotinamide adenine dinucleotide (NAD, NAD+, NADH) or nicotinamide mononucleotide (NMN) in the body.

Acne medication warnings further highlight potential risks of mood-related changes and sexual disorders.

Magnum XXL capsules pose a serious risk to your health and should not be taken.

Further examples of counterfeit Ozempic-labelled products have been detected and stopped at the Australian border.